Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean–Congo Hemorrhagic Fever Virus Nucleoprotein

Crimean–Congo hemorrhagic fever virus (CCHFV) infrequently causes hemorrhagic fever in humans with a case fatality rate of 30%. Currently, there is neither an internationally approved antiviral drug nor a vaccine against the virus. A replicon based on the Sindbis virus vector encoding the complete o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tipih, Thomas, Heise, Mark, Burt, Felicity Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703447/
https://www.ncbi.nlm.nih.gov/pubmed/34960237
http://dx.doi.org/10.3390/vaccines9121491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703447/
https://www.ncbi.nlm.nih.gov/pubmed/34960237
http://dx.doi.org/10.3390/vaccines9121491

Ejemplares similares